Use of an antimicrobial agent to prevent complications following transurethral resection of the prostate. Furadantin.
D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D009582:Nitrofurantoin / Q000627:therapeutic use*; D010919:Placebos; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000601:surgery; D011471:Prostatic Neoplasms / Q000601:surgery; D018805:Sepsis / Q000517:prevention & control*; D014552:Urinary Tract Infections / Q000517:prevention & control*
D010919:Placebos; D009582:Nitrofurantoin